Skip to main content

Table 1 Respirologist-adjudicated decisions about patients’ asthma classifications and treatments, for cases where ERS/ATS 2014 guidelines were unclear

From: Asthma severity in four countries of Latin America

Treatment scheme not clearly defined by ERS/ATS 2014

Classification decision – defined by 3 respirologists

1: Patients using non-high dose of ICS + LAMA

Severe asthma

2: Patients using non-high dose of ICS + LABA+Anti-IgE

Severe asthma

3: Patients using OCS with other controllers that are not ICS

Severe asthma

4: Patients using non-high dose of ICS + 2 or more controllers (leukotrienes receptor antagonist OR LABA OR xanthines (theophylline OR aminophylline)

Non-severe asthma

  1. ICS inhaled corticosteroids, LAMA long-acting muscarinic receptor antagonist, LABA long-acting beta2 -agonist, Anti-IgE anti-immunoglobulin E, OCS oral corticosteroid